15 Sources
[1]
Anthropic's Claude Science bets on workflow, not a new model, to win over scientists
Anthropic introduced Claude Science on Tuesday, an AI workbench that gives scientists one environment to do computational research, sparing them the hassle of bouncing between databases, pipelines, and tools. To be clear, Anthropic says Claude Science is "not a new AI model and not a more capable
[2]
Claude Science is Anthropic's newest flagship product
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering. Like Claude Code, Claude Science can autonomously
[3]
Anthropic wants to develop its own drugs
At the event "The Briefing: AI for Science" earlier this week, Anthropic announced Claude Science, a new "AI workbench for scientists" that pulls fragmented tools and datasets into one environment, and generates figures and visuals. Anthropic, already dominating the industry with its popular coding
[4]
Anthropic launches Claude Science in push for pharma revenue
Anthropic has launched an AI product aimed at scientists and pharmaceutical groups, as the $900bn company seeks to expand its enterprise business and boost revenues ahead of its planned initial public offering. The San Francisco-based start-up announced Claude Science on Tuesday, its first product
[5]
Anthropic launches Claude Science, an AI lab workbench
Claude Science folds a scientist's scattered tools into one app and lets AI agents run analysis end to end, with a reviewer agent to check the citations and maths. It is Anthropic's deepest move into the lab, and a revenue bet ahead of a planned listing. Anthropic has launched Claude Science, an
[6]
Anthropic just released a brand-new Claude Science app for Mac
Anthropic just launched a brand-new desktop app called Claude Science. The new app joins the main Claude app on the Mac, which includes Claude AI, Cowork, and Code. The new Claude Science app arrives in beta today for macOS and Linux. Anthropic says it "runs analyses, searches databases, and
[7]
Anthropic launches "AI workbench" for scientists using Claude
Claude Science aims to be a unified research package for scientists * Claude Science is a new "workbench" to consolidate fragmented research workflows * Everything from literature review to publication is handled on private infrastructure * Anthropic continues to roll out industry-specific AI
[8]
Anthropic launches Claude Science app for researchers and scientists
The company said it wanted to remove the tedious procedural aspects inherent to scientific research by uniting fragmented tools, resources, file formats and databases. Anthropic, the AI company behind Claude and Mythos, has unveiled its 'Claude Science' offering, which it described as "an AI
[9]
5 takeaways from Anthropic's big science event
On June 30, at an Anthropic event in San Francisco called "The Briefing: AI for Science," Amodei didn't declare that AI's impact on biology and other sciences had unleashed that effect, or was about to pull it off. Instead, he emphasized that he doesn't expect it to transpire in the next couple of
[10]
Anthropic launches Claude Science workbench for researchers
Anthropic introduced Claude Science on Tuesday, an AI workbench aimed at facilitating computational research for scientists by consolidating various databases, pipelines, and tools into a single environment. The company clarified that Claude Science is "not a new AI model and not a more capable
[11]
The New Anthropic Tool That Could Change How Drugs Are Developed
The launch marks the frontier AI lab's most significant move yet into life sciences. Anthropic says Claude Science integrates more than 60 preconfigured tools and connectors into "a single research environment" and provides access to local, remote, and high-performance computing resources. "AI has
[12]
Anthropic unveils 'Claude Science' AI platform for scientific research
The launch is part of Anthropic's life sciences and healthcare initiative, which the IPO-bound company has been developing since October 2025. Anthropic on Tuesday launched Claude Science, an AI platform designed to help scientists streamline research, analyze data and manage complex computing
[13]
Anthropic launches Claude Science workbench for researchers By Investing.com
Investing.com - Anthropic released Claude Science on Tuesday, an AI workbench designed to consolidate scientific research tools into a single environment for conducting literature analysis, executing multistep research, and producing auditable artifacts. The app integrates over 60 curated skills
[14]
Anthropic launches AI drug discovery project: neglected diseases first
Claude Science targets preclinical genomics with links to 60 databases Anthropic launched its drug discovery program today. It's a clear move into neglected-disease research, and it also introduces Claude Science, the company's workbench for genomics, proteomics, and single-cell analysis. The
[15]
Anthropic Claude Science explained: An AI lab bench that lives inside your terminal
Anthropic has released Claude Science, which is essentially a workbench for AI researchers that tackles one of the least glamorous aspects of scientific research - the sheer burden of administration. In scientific research, there are many databases each having different schemas, incompatible file
Share
Copy Link
Anthropic unveiled Claude Science, an AI workbench for scientists that consolidates fragmented research tools into one environment. The company is also taking a bold step by announcing plans to develop its own drugs for neglected diseases, positioning itself as both a software provider and potential competitor to pharmaceutical companies already using its platform.
Anthropic introduced Claude Science on Tuesday, marking its most significant push into AI for science with a dedicated workbench that consolidates the scattered databases, pipelines, and tools scientists typically juggle during computational research
1
. The product, now available in beta to anyone on Pro, Max, Team, and Enterprise subscriptions, represents a strategic shift for the $900bn company as it seeks to expand its enterprise business ahead of a planned IPO4
.
Source: Digit
Crucially, Claude Science is not a new AI model. It runs the same Claude models already available to everyone, including Claude Opus 4.8, with no special access or gating
1
. This approach contrasts sharply with OpenAI's strategy, which released GPT-Rosalind in April—a specialized model fine-tuned for biological reasoning that launched as a research preview limited to qualified enterprise customers in the U.S.1
.At the core of Claude Science sits a coordinating AI agent that acts as a project manager, connecting to more than 60 scientific databases and drawing on pre-built toolkits for fields like genomics, protein structure, and chemistry
1
. This main assistant can create sub-assistants to divide work or hand tasks to custom expert assistants that users build for their own research. A separate reviewer agent then checks citations and calculations before publication, addressing the growing problem of fabricated citations and unverifiable statistics slipping into AI-assisted papers1
.
Source: TechCrunch
Reproducibility is central to the design. The workbench generates figures like 3D protein structures alongside the exact code and environment that produced them, complete with plain-language descriptions and full message history
1
. Scientists can edit these figures using natural language prompts, which causes the agent to rewrite its own underlying code5
. The system also runs on a lab's own infrastructure rather than sending data to Anthropic's servers, addressing privacy concerns around sensitive datasets1
.Early results from AI-driven scientific research demonstrate significant time savings. Sean Whalen, a principal scientist at Gladstone Institutes, built a genome browser from scratch in days using Claude Science, while Allen Institute neuroscientist Jérôme Lecoq created a multi-agent computational review pipeline that shaved years off human work
1
. Lecoq's system, which uses about 20 custom skills and multiple sub-agents to read thousands of papers and draft reviews section by section, reduced what used to take his team two years into a process that now produces about 10 reviews, many exceeding 100 pages5
.Novo Nordisk and the Allen Institute have been named as customer case studies, with Novo Nordisk using Claude for drug discovery, clinical documentation, regulatory submissions, and literature synthesis
4
. AstraZeneca has also deployed Claude to scale research and development efforts4
. This suggests major pharmaceutical companies are working with multiple AI vendors simultaneously, creating a competitive landscape where Anthropic must differentiate on workflow rather than model capability alone.In an unexpected move, Anthropic announced it would pursue its own drug development for neglected diseases, putting it in the unusual position of selling software to potentially competing drugmakers
3
. Eric Kauderer-Abrams, Anthropic's head of life sciences, revealed this plan at the AI for Science briefing but provided few specifics about what diseases the company would target first or whether it would partner with other firms for lab work, animal testing, clinical trials, or manufacturing3
.This represents one of the most direct public attempts by a major frontier AI company to actually develop drugs itself, placing Anthropic in a broader race that includes AI-first drug companies like Insilico, Google DeepMind spinout Isomorphic Labs, biotech startups, and Big Pharma companies building or acquiring AI tools
3
. The company will support up to 50 Claude Science projects with up to $30,000 in credits, focusing on postdoctoral and graduate projects spanning domains across biomedical research, with applications open through July 15, 20261
.Related Stories
The competitive landscape for AI in life sciences reveals distinct strategies. Google DeepMind owns foundational science models like AlphaFold and AlphaGenome, which competitors can only access as tools, and its Gemini for Science platform bundles these with more fairer than 30 life science databases
1
. Anthropic recently gained a scientific credibility boost when John Jumper, who won the Nobel Prize in chemistry for his work on AlphaFold at DeepMind, announced he was leaving for Anthropic2
.
Source: Softonic
Claude Science integrates with Nvidia's BioNeMo Agent Toolkit to access life-sciences models such as Evo 2, Boltz-2, and OpenFold3, alongside more than 60 scientific databases including UniProt, PDB, and ChEMBL
5
. This partnership with Nvidia reflects the chipmaker's broad strategy of spreading tools and resources across multiple fronts in AI-driven workflow automation.Despite the enthusiasm, experts caution that significant hurdles remain. Frank von Delft, a professor at the University of Oxford, noted that while advancing AI models deserve excitement, they haven't yet made experiments unnecessary
3
. Drug candidates still require real-world testing for efficacy, toxicity, and practical properties, all of which demand skilled workers, substantial funding, and time—especially during clinical trials when many promising candidates fail3
. Matthew Todd, a professor at University College London, emphasized that the field is still a long way from seeing an AI-designed drug approved by regulators for human use3
.Summarized by
Navi
[2]
[3]
[5]
20 Oct 2025•Science and Research

20 Aug 2026•Technology

05 Sept 2024
